Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
about
Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrestLaminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factorNuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerPEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesAnti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-reviewThe role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimusSecreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathwayRSK2 mediates muscle cell differentiation through regulation of NFAT3.Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma (PPARgamma).Molecular determinants of NOTCH4 transcription in vascular endothelium.Transcriptional regulation of bone and joint remodeling by NFATRocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression.NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement.c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cellsChanges in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factorPigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis.Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapyCell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular.Efficacy of continuously administered PEDF-derived synthetic peptides against osteosarcoma growth and metastasisNFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.NFAT as cancer target: mission possible?Expression of pigment epithelium-derived factor is associated with a good prognosis and is correlated with epithelial-mesenchymal transition-related genes in infiltrating ductal breast carcinoma.Thrombospondin-1 and pigment epithelium-derived factor enhance responsiveness of KM12 colon tumor to metronomic cyclophosphamide but have disparate effects on tumor metastasis.The interleukin-1 receptor associated kinase 1 contributes to the regulation of NFATThe effects of PEDF on cancer biology: mechanisms of action and therapeutic potentialA novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.Therapeutic molecular targets in human chondrosarcoma.Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.The emerging role of PEDF in stem cell biology.NFAT gene family in inflammation and cancer.The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?Targeting angiogenesis and the tumor microenvironment.The Far Side of Vascular Injury: Nonconventional Vasoconstrictors, DNA-targeting Agents, and Agents Toxic to Vascular Smooth Muscle.TRPV4 channels: physiological and pathological role in cardiovascular system.RSK2 and its binding partners in cell proliferation, transformation and cancer development.Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation.'Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'.
P2860
Q24632971-340186DD-8400-480B-87CC-BC147D48ED53Q24644856-3A60F1B8-47C9-4838-8AD0-E062562FBD52Q26824937-C47252F2-9EB2-4906-9BD2-27379B6F865AQ27026916-E0587793-8C6C-4EA9-A8FA-767592C7FDA3Q28067001-8924D630-D8BA-4C2D-AD23-2D9AD1AE11CCQ28478436-41C1A70D-88DC-4B74-B547-3649ED966AA7Q28505775-999ECA1A-0E4A-4B91-B9BD-102EAC339E64Q30437023-03347E2E-5A1D-469B-B9E2-57F47A6CFF3DQ33604236-366D2C1D-48B9-4826-944D-B4C0D2EF643FQ33789026-91D09C2B-C0B9-4E37-99A0-4BD78005A30CQ33809978-0C0EEF35-F404-491E-9170-5CF9FB96E1E8Q33823770-5D828597-3573-4AF6-9A27-1AAA964936BAQ33998768-1CD470D0-EB81-476F-80CC-62151582112BQ34017088-AAA7FD67-0AD6-47C5-8AAB-85EAD7DCBF11Q34033879-A0EB8B7E-331A-4D97-BB3F-92E31C010CC8Q34139663-ECF50984-0EB6-4603-8DB6-4E2643A80D3AQ35091440-794D515B-C57B-4244-A05E-8354876E97E7Q35095249-62608D2B-EF44-469B-8441-DC37A827E025Q35800448-E5976AC3-F120-4EA7-8CB0-13A555770E27Q36011832-B1ACF459-5D04-4DF3-9076-E3BC4CBF7753Q36014753-578BD788-7369-420C-B1CA-10C4360B75A5Q36434003-0795157F-AB0C-4666-A280-9FF4AE7DBB74Q36455193-2757B8BF-D181-47D6-98C9-65CF810D7EDAQ36503117-9A4B49B7-8DFE-4503-866A-F710EB56D0B3Q36586178-BAAD5A44-70E3-4F5E-AC12-6E29F014F5F3Q36965348-0B2206C9-DF57-4D35-90C9-1AC6298D6A8DQ37000498-747CD102-A1F3-4252-A6F0-35D6263FECDFQ37192255-7F128440-F508-4BFB-88AC-52D3C298AED3Q37294120-9AEB079B-B844-445B-ACC4-8C9F528E5AEFQ37809576-6FB775F1-895A-457C-A772-130B44CCF7CDQ37963916-0309B2E7-6454-4FFC-B3DA-666F8A0AD279Q38016850-4974B4A6-7721-44A6-8335-1E7D8CB7A68CQ38040813-77331C3E-7F32-46BD-B54E-11366006B6EFQ38103913-5EF45969-79FE-4F77-BD41-AC9A21E9C8CEQ38135123-93FB1414-9F65-42C5-8808-AD12892D32CCQ38583684-B803C5CB-A25D-4612-9257-D6E646671174Q38594754-45DF0D2D-3958-42EB-A930-4440015E1B63Q39053415-128B0F59-0098-401B-9CC8-02766BFC6461Q39692548-09FD3EE0-4195-422F-A9E4-2E9F78BECA6DQ39797139-B3334679-6312-4D50-998E-0EBC2D213072
P2860
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
@ast
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
@en
type
label
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
@ast
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
@en
prefLabel
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
@ast
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
@en
P2093
P2860
P356
P1476
Nuclear factor of activated T cells balances angiogenesis activation and inhibition
@en
P2093
Emelyn H Shroff
Rebekah Emmanuel
Tetiana A Zaichuk
Thomas Nelius
P2860
P304
P356
10.1084/JEM.20040474
P407
P577
2004-06-01T00:00:00Z